HealthDay
(12/29, Mann) reports, "Severely ill hospital patients are at high
risk for developing potentially fatal blood clots, and often wear
compression stockings and/or take blood thinners to help lower this
risk. However, adding the blood thinner Lovenox (enoxaparin) to the mix
does not reduce their chances of dying from a blood clot, according to research
appearing in the Dec. 29 issue of the New England Journal of
Medicine." For patients who "were given Lovenox, the risk of death from
any cause was 4.9 percent," while "this risk was 4.8 percent among those
participants who were given a placebo."
According to MedPage Today
(12/29, Walsh), researchers "noted that, while thromboprophylaxis in
surgical patients has been shown to decrease the rate of lethal
pulmonary embolism, acutely ill medical patients may be at risk for
death from many causes other than pulmonary embolism, 'thus diminishing
the ability of pharmacologic prophylaxis to improve the overall clinical
outcome.'" In addition, the study took place in "193 centers, most of
which were in India or China," and "rates of
pulmonary embolism have been reported to be lower in Asia than in
Western countries." Other explanations include "that the use of
compression stockings alone was sufficient to prevent the development of
the venous clots that can ultimately lead to pulmonary embolism" or
"that their study population may have been at a lower risk for
thromboembolism than in other studies, by being younger and less likely
to be obese, as well as in having low rates of previous thromboembolic
events."
No comments:
Post a Comment